TC Energy Corporation (TRP)
NYSE: TRP · Real-Time Price · USD
50.99
+0.90 (1.80%)
Aug 13, 2025, 12:58 PM - Market open
Singular Genomics Systems Stock Forecast
Stock Price Forecast
The 3 analysts that cover Singular Genomics Systems stock have a consensus rating of "Hold" and an average price target of $62, which forecasts a 21.59% increase in the stock price over the next year. The lowest target is $42 and the highest is $74.
Price Target: $62 (+21.59%)
Analyst Consensus: Hold
* Price targets were last updated on Feb 18, 2025.
Analyst Ratings
The average analyst rating for Singular Genomics Systems stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 | Aug '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 1 | 1 | 1 | 1 | 1 | 1 |
| Total | 3 | 3 | 3 | 3 | 3 | 3 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| RBC Capital | RBC Capital | Buy Maintains $71 → $74 | Buy | Maintains | $71 → $74 | +45.13% | Feb 18, 2025 |
| BMO Capital | BMO Capital | Hold Maintains $66 → $70 | Hold | Maintains | $66 → $70 | +37.28% | Nov 20, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $38 → $42 | Strong Sell | Maintains | $38 → $42 | -17.63% | Oct 21, 2024 |
| Barclays | Barclays | Hold Maintains $53 → $55 | Hold | Maintains | $53 → $55 | +7.86% | Jan 29, 2024 |
| Goldman Sachs | Goldman Sachs | Strong Sell Maintains $29 → $32 | Strong Sell | Maintains | $29 → $32 | -37.24% | Jan 26, 2024 |
Financial Forecast
Revenue This Year
15.22B
from 13.77B
Increased by 10.54%
Revenue Next Year
16.13B
from 15.22B
Increased by 5.95%
EPS This Year
3.81
from 4.43
Decreased by -13.97%
EPS Next Year
4.08
from 3.81
Increased by 7.15%
Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 16.7B | 17.6B | 18.1B | |
| Avg | 15.2B | 16.1B | 16.5B | |
| Low | 14.2B | 14.9B | 15.4B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 21.5% | 15.9% | 12.5% | |
| Avg | 10.5% | 6.0% | 2.6% | |
| Low | 3.3% | -2.1% | -4.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 4.84 | 5.39 | 5.06 | ||
| Avg | 3.81 | 4.08 | 4.12 | ||
| Low | 3.35 | 3.51 | 3.54 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 9.4% | 41.5% | 24.0% | ||
| Avg | -14.0% | 7.2% | 1.0% | ||
| Low | -24.3% | -7.9% | -13.3% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.